MedTrace Logo

Efficacy and Safety of Diabetes-specific Formula in Patients With Type 2 Diabetes Mellitus

NCT04622722 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-10-03

No results posted yet for this study

Summary

Hypothesis: the diabetes-specific formula Nutren diabetes provides better postprandial glucose control in patients with type 2 diabetes when compared to the isocaloric diet.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

Nutren Diabetes

Nutren Diabetes provides energy at 360 kcal per 360 ml

OTHER

Isocaloric

Isocaloric diet One carton of soy milk (250 ml) and bologna sandwiches (two slices of bread) with mayonnaise

Sponsors & Collaborators

  • Ramathibodi Hospital

    collaborator OTHER

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Daruneewan Warodomwichit · Division of Nutrition & Biochemical Medicine, Department of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-22
Primary Completion
2020-05-16
Completion
2020-05-16

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04622722 on ClinicalTrials.gov